Loading
A phase 3 trial of aspirin in colorectal cancer, run by University Hospital, Antwerp, active but no longer recruiting.
ASPIRIN Trial Belgium is a phase 3, randomised interventional study registered as NCT03464305 by University Hospital, Antwerp, with a registry enrolment figure of 148 participants, started 2018-02-22 and due to reach its primary completion in 2027-12-31. Interventions recorded: acetylsalicylic acid; Placebo. Conditions listed: Colon Cancer. Primary outcome: 5 year overall survival. Colorectal eligibility wording from the registry: "* Patients 45 years and older with histologically confirmed adenocarcinoma of the colon". Sites: Belgium. No results are recorded here; the registry entry is the source.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.